Clinical trial Recruiting at 1 site Observational Ages 18 and up

New ways to estimate left heart pressures in people with heart failure and atrial fibrillation

Official title: Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation: A Prospective Multicenter Study

Run by Oslo University Hospital · NCT07436299 · Data updated 2026-11-12

This study tests a new approach that combines ultrasound and clinical data to see if doctors can better tell when the heart’s filling pressure is high in patients who have both heart failure and atrial fibrillation.

More Atrial Fibrillation (AF) trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment400 (estimated)
SponsorOslo University Hospital
Academic / other
Locations15 sites (Cleveland, Ohio and 14 other locations)
StatusRecruiting
StartedSeptember 2026
Main results expectedJanuary 2028
Study endsDecember 2029
Registry record updatedSeptember 10, 2026
Trial IDNCT07436299 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with atrial fibrillation scheduled for invasive pressure measurement who can undergo echocardiography within eight hours of catheterization and have no recent cardiovascular medication changes.

Probably not a fit

Patients not undergoing catheterization or with exclusion criteria (e.g., significant valvular disease, prosthetic valves, pregnancy, LVAD, or non-cardiac comorbidity with poor prognosis) may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, multicenter observational study will enroll about 400 patients with atrial fibrillation who are undergoing right or left heart catheterization. It aims to develop and validate an algorithm that uses echocardiographic and clinical parameters to distinguish normal from elevated left ventricular filling pressure with at least 80% diagnostic accuracy. Secondary goals include identifying imaging predictors of abnormal pressure elevation during exercise and finding imaging markers linked to mortality and heart-failure outcomes over three years. Echocardiography will be performed in relation to catheterization, without changing cardiovascular medications within eight hours. An exercise substudy will explore predictors of increased wedge pressure during exertion.

Why it matters

Potential benefit: If successful, the algorithm could improve accuracy in diagnosing and predicting outcomes for HF patients with AF, potentially guiding treatment decisions.

How similar studies have gone: Prior multicenter AF studies support feasibility of large-gauge enrollment; however, this specific combined imaging-clinical algorithm for AF-related LVFP is novel but builds on established methods.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Atrial fibrillation (paroxysmal, persistent, or permanent)
* Scheduled for RHC or LHC for clinical reasons
* Able to undergo echocardiography and invasive pressure measurement within 8 hours
* No cardiovascular medication changes between echo and catheterization
* Written informed consent provided

Exclusion Criteria:

* Mitral stenosis or mitral annular calcification causing severe functional stenosis
* Severe mitral or severe tricuspid regurgitation
* Prosthetic mitral valve
* Atrial fibrillation with rapid ventricular response \>120 bpm
* Suboptimal echocardiographic imaging
* Conditions rendering PCWP or LVEDP unreliable
* Pregnant women
* Complex congenital heart disease
* LV assist device and patients with severe non-cardiac disease with poor prognosis
* Cardiac transplant patients
* End-stage liver disease

Where it's running

  • Division of Cardiovascular & Pulmonary Diseases, Oslo University Hospital
    Oslo, Oslo, Norway
    Recruiting
  • Cleveland Clinic
    Cleveland, Ohio, United States
    Not yet recruiting
  • Methodist DeBakey Heart and Vascular Center
    Houston, Texas, United States
    Not yet recruiting
  • Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium
    Aalst, Belgium
    Not yet recruiting
  • Catholic University of Leuven
    Leuven, Belgium
    Not yet recruiting
  • Laboratory Signal Processing and Image, Department of Cardiology
    Rennes, France
    Not yet recruiting
Show 9 more locations
  • Service de Cardiologie, Hôpitaux Universitaires de Strasbourg
    Strasbourg, France
    Not yet recruiting
  • Nagoya City University Graduate School of Medical Sciences
    Nagoya, Aichi-ken, Japan
    Not yet recruiting
  • Ehime University
    Tōon, Ehime, Japan
    Not yet recruiting
  • University of Auckland
    Auckland, Auckland, New Zealand
    Not yet recruiting
  • Carol Davila University of Medicine and Pharmacy
    Bucharest, Romania
    Not yet recruiting
  • The Department of Cardiology at the Ljubljana University Medical Centre
    Ljubljana, Slovenia
    Not yet recruiting
  • Yonsei University College of Medicine
    Seoul, Seoul, South Korea
    Not yet recruiting
  • Department of Cardiovascular Sciences, University of Birmingham
    Birmingham, United Kingdom
    Not yet recruiting
  • King's College
    London, United Kingdom
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.